{"abstract": "Six years after the Affordable Care Act cleared the way for biosimilars, as the generic versions of biotechnology drugs are called, progress has been slow.", "web_url": "https://www.nytimes.com/2016/07/16/business/makers-of-humira-and-enbrel-using-new-drug-patents-to-delay-generic-versions.html", "snippet": "Six years after the Affordable Care Act cleared the way for biosimilars, as the generic versions of biotechnology drugs are called, progress has been slow.", "lead_paragraph": "The best-selling drugs Humira and Enbrel have a lot in common. They both use biotechnology to treat rheumatoid arthritis, psoriasis and other autoimmune diseases. And they come with giant price tags approaching $50,000 a year.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2016/07/16/business/16DRUG-1/16DRUG-1-articleLarge.jpg", "height": 851, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2016/07/16/business/16DRUG-1/16DRUG-1-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 851}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2016/07/16/business/16DRUG-1/16DRUG-1-jumbo.jpg", "height": 1024, "width": 723, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2016/07/16/business/16DRUG-1/16DRUG-1-superJumbo.jpg", "height": 2048, "width": 1445, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2016/07/16/business/16DRUG-1/16DRUG-1-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2016/07/16/business/16DRUG-1/16DRUG-1-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2016/07/16/business/16DRUG-1/16DRUG-1-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Makers of Humira and Enbrel Using New Drug Patents to Delay Generic Versions", "kicker": null, "content_kicker": null, "print_headline": "New Patents Aim to Delay Generics of Biologics", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "persons", "value": "Pollack, Andrew", "rank": 2, "major": "N"}, {"name": "subject", "value": "Biotechnology and Bioengineering", "rank": 3, "major": "N"}, {"name": "subject", "value": "Generic Brands and Products", "rank": 4, "major": "N"}, {"name": "subject", "value": "Prices (Fares, Fees and Rates)", "rank": 5, "major": "N"}, {"name": "organizations", "value": "AMGEN INC", "rank": 6, "major": "N"}, {"name": "organizations", "value": "AbbVie Inc", "rank": 7, "major": "N"}, {"name": "subject", "value": "Patient Protection and Affordable Care Act (2010)", "rank": 8, "major": "N"}, {"name": "subject", "value": "Health Insurance and Managed Care", "rank": 9, "major": "N"}], "pub_date": "2016-07-15T23:45:13+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Andrew Pollack", "person": [{"firstname": "Andrew", "middlename": null, "lastname": "Pollack", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/781638b3-86bb-550c-94a0-d9f71db0317e", "word_count": 1057, "uri": "nyt://article/781638b3-86bb-550c-94a0-d9f71db0317e"}